BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

611 related articles for article (PubMed ID: 7526465)

  • 1. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions.
    Feng S; Chen JK; Yu H; Simon JA; Schreiber SL
    Science; 1994 Nov; 266(5188):1241-7. PubMed ID: 7526465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the binding of proline-rich peptides to SH3 domains.
    Yu H; Chen JK; Feng S; Dalgarno DC; Brauer AW; Schreiber SL
    Cell; 1994 Mar; 76(5):933-45. PubMed ID: 7510218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
    Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the N-terminal SH3 domain of GRB2 complexed with a peptide from the guanine nucleotide releasing factor Sos.
    Terasawa H; Kohda D; Hatanaka H; Tsuchiya S; Ogura K; Nagata K; Ishii S; Mandiyan V; Ullrich A; Schlessinger J
    Nat Struct Biol; 1994 Dec; 1(12):891-7. PubMed ID: 7773778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions.
    Simon JA; Schreiber SL
    Chem Biol; 1995 Jan; 2(1):53-60. PubMed ID: 9383403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands.
    Feng S; Kasahara C; Rickles RJ; Schreiber SL
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12408-15. PubMed ID: 8618911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from Sos.
    Goudreau N; Cornille F; Duchesne M; Parker F; Tocqué B; Garbay C; Roques BP
    Nat Struct Biol; 1994 Dec; 1(12):898-907. PubMed ID: 7773779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the SH3 domain of human osteoclast-stimulating factor with rationally designed peptoid inhibitors.
    Han S; Liu Q; Wang F; Yuan Z
    J Pept Sci; 2016 Aug; 22(8):533-9. PubMed ID: 27443979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The crystal structure of the N-terminal SH3 domain of Grb2.
    Guruprasad L; Dhanaraj V; Timm D; Blundell TL; Gout I; Waterfield MD
    J Mol Biol; 1995 May; 248(4):856-66. PubMed ID: 7752246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2.
    Xu XX; Yi T; Tang B; Lambeth JD
    Oncogene; 1998 Mar; 16(12):1561-9. PubMed ID: 9569023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Directed discovery of bivalent peptide ligands to an SH3 domain.
    Ferguson MR; Fan X; Mukherjee M; Luo J; Khan R; Ferreon JC; Hilser VJ; Shope RE; Fox RO
    Protein Sci; 2004 Mar; 13(3):626-32. PubMed ID: 14978303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orientation of peptide fragments from Sos proteins bound to the N-terminal SH3 domain of Grb2 determined by NMR spectroscopy.
    Wittekind M; Mapelli C; Farmer BT; Suen KL; Goldfarb V; Tsao J; Lavoie T; Barbacid M; Meyers CA; Mueller L
    Biochemistry; 1994 Nov; 33(46):13531-9. PubMed ID: 7947763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proline-rich sequences that bind to Src homology 3 domains with individual specificities.
    Alexandropoulos K; Cheng G; Baltimore D
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3110-4. PubMed ID: 7536925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular dichroic investigation of the native and non-native conformational states of the growth factor receptor-binding protein 2 N-terminal src homology domain 3: effect of binding to a proline-rich peptide from guanine nucleotide exchange factor.
    Bousquet JA; Garbay C; Roques BP; Mély Y
    Biochemistry; 2000 Jul; 39(26):7722-35. PubMed ID: 10869177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disrupting the intramolecular interaction between proto-oncogene c-Src SH3 domain and its self-binding peptide PPII with rationally designed peptide ligands.
    Zhou P; Hou S; Bai Z; Li Z; Wang H; Chen Z; Meng Y
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1122-1131. PubMed ID: 28754059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl.
    Tzeng SR; Lou YC; Pai MT; Jain ML; Cheng JW
    J Biomol NMR; 2000 Apr; 16(4):303-12. PubMed ID: 10826882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure of the Grb2 N-terminal SH3 domain complexed with a ten-residue peptide derived from SOS: direct refinement against NOEs, J-couplings and 1H and 13C chemical shifts.
    Wittekind M; Mapelli C; Lee V; Goldfarb V; Friedrichs MS; Meyers CA; Mueller L
    J Mol Biol; 1997 Apr; 267(4):933-52. PubMed ID: 9135122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions.
    Weng Z; Rickles RJ; Feng S; Richard S; Shaw AS; Schreiber SL; Brugge JS
    Mol Cell Biol; 1995 Oct; 15(10):5627-34. PubMed ID: 7565714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tight association of GRB2 with receptor protein-tyrosine phosphatase alpha is mediated by the SH2 and C-terminal SH3 domains.
    den Hertog J; Hunter T
    EMBO J; 1996 Jun; 15(12):3016-27. PubMed ID: 8670803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.